Abstract:The mycorrhiza helper bacterium Streptomyces strain AcH 505 improves mycelial growth of ectomycorrhizal fungi and formation of ectomycorrhizas between Amanita muscaria and spruce but suppresses the growth of plant-pathogenic fungi, suggesting that it produces both fungal growth-stimulating and -suppressing compounds. The dominant fungal-growth-promoting substance produced by strain AcH 505, auxofuran, was isolated, and its effect on the levels of gene expression of A. muscaria was investigated. Auxofuran and i… Show more
“…AcH505 was shown to have a pronounced effect on the organization of the cytoskeleton of the ectomycorrhizal fungus Amanita muscaria (351). The same strain also produces auxofuran, a metabolite that contributes to its growth-promoting effect, the synthesis of which is promoted in bacterial-fungal cocultures and at acidic pH values that typify the growth conditions of ectomycorrhizal fungi (323).…”
Section: Consequences Of Bacterial-fungal Interactions For Participatmentioning
confidence: 99%
“…strain AcH505 also leads to the suppression of bacterial antibiotic production. In this case, the fungus represses the biosynthesis of the antibiotics WS-5995 B and WS-5995 C by organic acid production (323). Signaling-based interactions.…”
Section: Bacterial-fungal Molecular Interactions and Communicationmentioning
SUMMARY
Bacteria and fungi can form a range of physical associations that depend on various modes of molecular communication for their development and functioning. These bacterial-fungal interactions often result in changes to the pathogenicity or the nutritional influence of one or both partners toward plants or animals (including humans). They can also result in unique contributions to biogeochemical cycles and biotechnological processes. Thus, the interactions between bacteria and fungi are of central importance to numerous biological questions in agriculture, forestry, environmental science, food production, and medicine. Here we present a structured review of bacterial-fungal interactions, illustrated by examples sourced from many diverse scientific fields. We consider the general and specific properties of these interactions, providing a global perspective across this emerging multidisciplinary research area. We show that in many cases, parallels can be drawn between different scenarios in which bacterial-fungal interactions are important. Finally, we discuss how new avenues of investigation may enhance our ability to combat, manipulate, or exploit bacterial-fungal complexes for the economic and practical benefit of humanity as well as reshape our current understanding of bacterial and fungal ecology.
“…AcH505 was shown to have a pronounced effect on the organization of the cytoskeleton of the ectomycorrhizal fungus Amanita muscaria (351). The same strain also produces auxofuran, a metabolite that contributes to its growth-promoting effect, the synthesis of which is promoted in bacterial-fungal cocultures and at acidic pH values that typify the growth conditions of ectomycorrhizal fungi (323).…”
Section: Consequences Of Bacterial-fungal Interactions For Participatmentioning
confidence: 99%
“…strain AcH505 also leads to the suppression of bacterial antibiotic production. In this case, the fungus represses the biosynthesis of the antibiotics WS-5995 B and WS-5995 C by organic acid production (323). Signaling-based interactions.…”
Section: Bacterial-fungal Molecular Interactions and Communicationmentioning
SUMMARY
Bacteria and fungi can form a range of physical associations that depend on various modes of molecular communication for their development and functioning. These bacterial-fungal interactions often result in changes to the pathogenicity or the nutritional influence of one or both partners toward plants or animals (including humans). They can also result in unique contributions to biogeochemical cycles and biotechnological processes. Thus, the interactions between bacteria and fungi are of central importance to numerous biological questions in agriculture, forestry, environmental science, food production, and medicine. Here we present a structured review of bacterial-fungal interactions, illustrated by examples sourced from many diverse scientific fields. We consider the general and specific properties of these interactions, providing a global perspective across this emerging multidisciplinary research area. We show that in many cases, parallels can be drawn between different scenarios in which bacterial-fungal interactions are important. Finally, we discuss how new avenues of investigation may enhance our ability to combat, manipulate, or exploit bacterial-fungal complexes for the economic and practical benefit of humanity as well as reshape our current understanding of bacterial and fungal ecology.
“…flavonoids (AMF) and furans (ECM), that facilitate the growth of fungal hyphae and the subsequent colonization of plant roots by ECM (Founoune et al 2002;Duponnois and Plenchette 2003;Aspray et al 2006;Riedlinger et al 2006) and AM fungi (Duponnois and Plenchette 2003;Hildebrandt et al 2002Hildebrandt et al , 2006. Hildebrandt et al (2002Hildebrandt et al ( , 2006 have demonstrated that certain compounds (including raffinose and other unidentified metabolites) produced by strains of Paenibacillus can directly enhance the growth of AMF extraradical mycelium.…”
Experiments suggest that biomass-derived black carbon (biochar) affects microbial populations and soil biogeochemistry. Both biochar and mycorrhizal associations, ubiquitous symbioses in terrestrial ecosystems, are potentially important in various ecosystem services provided by soils, contributing to sustainable plant production, ecosystem restoration, and soil carbon sequestration and hence mitigation of global climate change. As both biochar and mycorrhizal associations are subject to management, understanding and exploiting interactions between them could be advantageous. Here we focus on biochar effects on mycorrhizal associations. After reviewing the experimental evidence for such effects, we critically examine hypotheses pertaining to four mechanisms by which biochar could influence mycorrhizal abundance and/or functioning. These mechanisms are (in decreasing order of currently available evidence supporting them): (a) alteration of soil physico-chemical properties; (b) indirect effects on mycorrhizae through effects on other soil microbes; (c) plant-fungus signaling interference and detoxification of allelochemicals on biochar; and (d) provision of refugia from fungal grazers. We provide a roadmap for research aimed at testing these mechanistic hypotheses.
“…Two further metabolites did not correspond to any of the 834 reference compounds stored in our database. One of them was identified as anhydroSEK4b (3) [5], the second was named fogacin (1).…”
A new octaketide named fogacin (1) was isolated from Streptomyces sp. (strain Tü 6319). Furthermore two shunt metabolites, SEK4b (2) and anhydroSEK4b (3), were detected and identified as nonenzymatically cyclized products of polyketide intermediates built during the biosynthesis of actinorhodin. SEK4b (2) as well as anhydroSEK4b (3) were previously described as metabolites of genetically engineered strains.Keywords polyketides, biosynthesis, shunt metabolites, SEK4b, HPLC screening Freshly isolated strains from soils collected at various sites in Romania were included in our HPLC-diode array screening program to detect novel secondary metabolites. Strain Tü 6319 which was isolated from an industrial contaminated soil near Fogaras, Romania, drew our attention because of its characteristic metabolite pattern, which appears analyzing the culture filtrate extract. Three of the metabolites were identified by means of our HPLC-UV-Vis database [2] as SEK4b (2) [3], and germicidins A and B [4], respectively. Two further metabolites did not correspond to any of the 834 reference compounds stored in our database. One of them was identified as anhydroSEK4b (3) [5], the second was named fogacin (1).Strain Tü 6319 was examined for a number of key properties known to be of value in streptomycete systematics. The presence of LL-diaminopimelic acid in the peptidoglycan together with its colonial characteristics allowed its assignment to the genus Streptomyces. Strain Tü 6319 shared a high 16S rRNA gene sequence with the closely related type strains Streptomyces coelescens DSM 40421, S. violaceolatus DSM 40438 and S. violaceoruber DSM 40049.Batch fermentation of strain Tü 6319 was carried out in 10-liter stirred tank fermenters (New Brunswick) in a medium that consisted of oat meal 2.0% in tap water (pH 7.3). The fermentation was conducted at 27°C for 168 hours with an aeration rate of 0.5 v/v/m and agitation of 200 rpm. Addition of 3% DMSO to the medium increased the production of 1 by 33%, reaching a maximum value of 10 mg/liter after 168 hours. Compound 1 was isolated from the culture filtrate (13 liters), loaded onto an Amberlite XAD-16 column (8ϫ40 cm) and eluted by increasing concentrations of MeOH. The 40% MeOH fraction that contained 1 was concentrated in vacuo, adjusted to pH 2, and extracted with ethyl acetate. The raw material was separated on a LiChroprep Diol column (2.6ϫ40 cm; Merck) applying a linear gradient CH 2 Cl 2 to a content of 5% MeOH within 3 hours at a flow rate of 5 ml/minute. A further metabolite (3) was separated from 1, and both compounds were purified by subsequent column chromatography on Sephadex LH-20 and Fractogel TSK HW-40 (each column 1.5ϫ90 cm, flow rate 15 ml/hour) using MeOH as eluent. Pure 1 was obtained in an amount of 8 mg.The antimicrobial activities of fogacin (1) and anhydro SEK4b (3) were examined by an agar plate diffusion assays. Compound 3 revealed a moderate inhibitory activity against Bacillus subtilis DSM 10 and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.